aciclovir accord 25 mg/ml infuusiokonsentraatti, liuosta varten
accord healthcare b.v. - aciclovir - infuusiokonsentraatti, liuosta varten - 25 mg/ml - asikloviiri
diclofenac ratiopharm 11.6 mg/g geeli
teva b.v. - diclofenac diethylamine - geeli - 11.6 mg/g - diklofenaakki
diclofenac ratiopharm 23.2 mg/g geeli
teva b.v. - diclofenac diethylamine - geeli - 23.2 mg/g - diklofenaakki
iclusig
incyte biosciences distribution b.v. - ponatinib - leukemia, myeloid; leukemia, lymphoid - antineoplastic agents, protein kinase inhibitors - iclusig is indicated in adult patients withchronic phase, accelerated phase, or blast phase chronic myeloid leukaemia (cml) who are resistant to dasatinib or nilotinib; who are intolerant to dasatinib or nilotinib and for whom subsequent treatment with imatinib is not clinically appropriate; or who have the t315i mutationphiladelphia chromosome positive acute lymphoblastic leukaemia (ph+ all) who are resistant to dasatinib; who are intolerant to dasatinib and for whom subsequent treatment with imatinib is not clinically appropriate; or who have the t315i mutation. katso kohdat 4. 2 assessment of cardiovascular status prior to start of therapy and 4. 4 situations where an alternative treatment may be considered.
valganciclovir accord 450 mg tabletti, kalvopäällysteinen
orifarm oy - valganciclovir hydrochloride - tabletti, kalvopäällysteinen - 450 mg - valgansikloviiri
diclofenac rapid orifarm 50 mg tabletti, kalvopäällysteinen
orifarm generics a/s orifarm generics a/s - diclofenacum kalicum - tabletti, kalvopäällysteinen - 50 mg - diklofenaakki
diclomex 25 mg enterotabletti
ratiopharm gmbh - diclofenacum natricum - enterotabletti - 25 mg - diklofenaakki
aciclovir hexal infuusiokuiva-aine, liuosta varten
hexal a/s - aciclovirum - infuusiokuiva-aine, liuosta varten - asikloviiri
aciclovir sandoz 30 mg/ml silmävoide
sandoz a/s - aciclovirum - silmävoide - 30 mg/ml - asikloviiri
aciclovir sandoz 5 % emulsiovoide
sandoz a/s sandoz a/s - aciclovirum - emulsiovoide - 5 % - asikloviiri